Universitätsklinikum Jena

Hospital


Location: Jena, Germany (DE) DE

ISNI: 0000000085176224

ROR: https://ror.org/035rzkx15

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland (2019) Wolff D, Hilgendorf I, Wagner-Drouet E, Jedlickova Z, Ayuk F, Zeiser R, Schäfer-Eckart K, et al. Journal article Prognostic factors in ALS: a comparison between Germany and China (2019) Dorst J, Chen L, Rosenbohm A, Dreyhaupt J, Hübers A, Schuster J, Weishaupt JH, et al. Journal article Semantic segmentation of non-linear multimodal images for disease grading of inflammatory bowel disease: A segnet-based application (2019) Pradhan P, Meyer T, Stallmach A, Waldner M, Schmitt M, Popp J, Bocklitz T, Vieth M Conference contribution Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study (2019) Goebell P, Hermann E, Kube U, Doehn C, Marschner N, Dietel A, Blumenstengel K, et al. Journal article Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia (2018) Middeke JM, Rollig C, Kramer M, Kramer A, Bochtler T, Scholl S, Hochhaus A, et al. Conference contribution EZH2 Mutations and Impact on Clinical Outcome Analyzed in 1604 Patients with Acute Myeloid Leukemia (2018) Stasik S, Middeke JM, Kraemer M, Rollig C, Kramer A, Scholl S, Hochhaus A, et al. Conference contribution Nilotinib Vs Nilotinib Plus Pegylated Interferon-alpha2b Induction and Nilotinib or Pegylated Interferon-alpha2b Maintenance Therapy for Newly Diagnosed BCR-ABL plus Chronic Myeloid Leukemia Patients in Chronic Phase: Interim Analysis of the Tiger (CML V)-Study (2018) Hochhaus A, Saussele S, Baerlocher GM, Bruemmendorf TH, Burchert A, La Rosee P, Hasford J, et al. Conference contribution Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies (2018) Kalwak K, Bader P, Styczynski J, Gruhn B, Patrick K, Sedlacek P, Stachel D, et al. Conference contribution Fiber-Enhanced Raman Sensing of Cefuroxime in Human Urine (2018) Yan D, Frosch T, Kobelke J, Bierlich J, Popp J, Pletz MW, Frosch T Journal article Paramagnetic, NIR-luminescent Nd3+- and Gd3+-doped fluorapatite as contrast agent for multimodal biomedical imaging (2018) Tesch A, Roeder R, Zapf M, Ronning C, Warncke P, Fischer D, Herrmann KH, et al. Journal article